Hydrochloric Acid → HCID 86584233, compound
Reaction equation
[F:1][C:2]([F:33])([F:32])[C:3]1[CH:4]=[C:5]([CH:25]=[C:26]([C:28]([F:31])([F:30])[F:29])[CH:27]=1)[C:6]([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][C@H:9]1[CH2:14][C:15]1[CH:24]=[CH:23][C:22]2[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=2)[CH:16]=1)=[O:7].[C:34](=[O:37])([O-])[O-].[K+].[K+].[ClH:40]>CN(C)C=O.C(OCC)(=O)C>[ClH:40].[ClH:40].[F:31][C:28]([F:29])([F:30])[C:26]1[CH:25]=[C:5]([CH:4]=[C:3]([C:2]([F:1])([F:32])[F:33])[CH:27]=1)[C:6]([N:8]1[CH2:13][CH2:12][N:11]([CH2:3][C:4]#[C:5][CH2:6][N:8]2[CH2:13][CH2:34][O:37][CH2:10][CH2:9]2)[CH2:10][C@H:9]1[CH2:14][C:15]1[CH:24]=[CH:23][C:22]2[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=2)[CH:16]=1)=[O:7]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(2-naphthylmethyl)piperazine (200 mg) and 1-(4-chloro-2-butynyl)morpholine hydrochloride (95 mg) in N,N-dimethylformamide (0.5 ml) was stirred at room temperature in the presence of powdered potassium carbonate (177 mg). After 17 hours, the reaction mixture was diluted with ethyl acetate (30 ml) and then washed successively with water and brine, and dried over magnesium sulfate. After evaporation of the solvent in vacuo, the resulting residue was purified by column chromatography on silica gel using ethyl acetate as an eluent. The product obtained was dissolved in ethyl acetate and treated with 4N hydrogen chloride in ethyl acetate solution to give (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-(4-morpholino-2-butynyl)-2-(2-naphthylmethyl)piperazine dihydrochloride (257 mg).
Workup
- washwashed successively with water and brine
- dry with materialdried over magnesium sulfate
- customAfter evaporation of the solvent in vacuo
- customthe resulting residue was purified by column chromatography on silica gel
- customThe product obtained
Sources & evidence
- ORD record
- ord-c2fb2eb754144420bea0ff3f7012db68
- Source dataset
- uspto-grants-2000_07
- Patent number
- US06087357
Reaction notes
Loading…